Loss of Activator Protein-2α Results in Overexpression of Protease-activated Receptor-1 and Correlates with the Malignant Phenotype of Human Melanoma

This publication has 48 references indexed in Scilit:

• Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo
  Oncogene, 2001
• Expression of AP‐2 transcription factor and of its downstream target genes c‐kit, E‐cadherin and p21 in human cutaneous melanoma
  Journal of Cellular Biochemistry, 2001
• Role of AP-2 in Tumor Growth and Metastasis of Human Melanoma
  Cancer and Metastasis Reviews, 1999
• Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.
  Journal of Clinical Oncology, 1998
• Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
  The EMBO Journal, 1998
• Loss of AP-2 Results in Up-regulation ofMCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells
  Journal of Biological Chemistry, 1998
• Melanoma progression–associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand
  International Journal of Cancer, 1997
• AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
  Nature Genetics, 1997
• Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene
  Proceedings of the National Academy of Sciences, 1996
• The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.
  Proceedings of the National Academy of Sciences, 1995